Consequently, inhibition of CD39 counteracted NSCLC-induced T cell mal-differentiation, resulting in increased Teff cells and decreased Treg cells (Fig. 3G, H, S5B–C). Here, ENTPD1 is linked to non-small cell lung carcinoma.